Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3879138

CC(C)N1CCN(c2cc(-c3ccccc3C(F)(F)F)nc(C#N)n2)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 2/20 0.48
CYP1A2 P05177 3/20 0.43
CYP2C19 P33261 3/20 0.43
L3MBTL1 Q9Y468 1/20 0.41
CTSS P25774 4/20 0.40
DRD2 P14416 2/20 0.38
HTR6 P50406 1/20 0.38
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
GBA1 P04062 1/20 0.36
CNR2 P34972 1/20 0.36
HRH3 Q9Y5N1 1/20 0.35
KMO O15229 2/20 0.35
DPP4 P27487 1/20 0.35
DPP7 Q9UHL4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3873560 0.93 CTSK (0.54) CTSKCYP1A2CYP2C19CTSSDRD2
Trifluoroacetic Acid SCHEMBL27718837 0.83 CTSK (0.46) CTSKCTSSDRD2HTR6CYP3A4
Trifluoroacetic Acid SCHEMBL3882810 0.83 CTSK (0.46) CTSKCYP1A2CYP2C19L3MBTL1CTSS
SCHEMBL3873575 0.77 CTSK (0.51) CTSKCYP1A2CYP2C19CTSSKDM4E
Hydrochloric Acid SCHEMBL3885789 0.77 CTSK (0.50) CTSKCYP1A2CYP2C19CTSSKDM4E
SCHEMBL3873562 0.75 CTSK (0.52) CTSKCTSSDRD2HTR6CYP3A4
SCHEMBL3875249 0.75 CTSK (0.51) CTSKCYP1A2CYP2C19CTSSDRD2
Trifluoroacetic Acid SCHEMBL3877715 0.70 TSHR (0.52) CTSKCTSSDRD2ALDH1A1TSHR
Trifluoroacetic Acid SCHEMBL3888320 0.69 CTSS (0.53) CTSKCTSSKDM4EALDH1A1HRH3
Trifluoroacetic Acid SCHEMBL3877719 0.68 CTSK (0.57) CTSKCYP1A2CYP2C19CTSSCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928842-B1 4-PHENYL-6-SUBSTITUTED-PYRIMIDINE-2-CARBONITRILE DERIVATIVES ORGANON NV (NL) 2009-11-18 EP disclosed
EP-1928842-A1 4-PHENYL-6-SUBSTITUTED-PYRIMIDINE-2-CARBONITRILE DERIVATIVES N.V. Organon (NL) 2008-06-11 EP disclosed
US-7326715-B2 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives N.V. ORGANON (NL) 2008-02-05 US disclosed
US-20070111992-A1 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives N.V. ORGANON (NL) 2007-05-17 US disclosed
WO-2007039470-A1 4-PHENYL-6-SUBSTITUTED-PYRIMIDINE-2-CARBONITRILE DERIVATIVES N.V. ORGANON (NL) 2007-04-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070111992-A1 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives CTSK, CTSS, CTSF CTSK 1/4885CYP1A2 2048/4885CYP2C19 759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.